{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:53:39Z","timestamp":1791978819105,"version":"4.4.0"},"reference-count":80,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The European and American guidelines offer recommendations for the management of antithrombotic medication following mitral valve interventions. Evidence to support recommendations is frequently extrapolated from studies of aortic valve procedures, despite thrombotic risk being substantially higher in mitral valve disease and mitral valve procedures. This review examines the pathophysiological basis for thrombosis in mitral valve conditions, the recommendations and evidence from the guidelines, and current uncertainties.<\/jats:p>","DOI":"10.1093\/ejcts\/ezag204","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:14:22Z","timestamp":1785323662000},"source":"Crossref","is-referenced-by-count":0,"title":["Anti-thrombotic Therapy After Mitral Valve Surgery"],"prefix":"10.1093","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5028-5505","authenticated-orcid":false,"given":"Bilal H","family":"Kirmani","sequence":"first","affiliation":[{"name":"Cardiac Surgery, Liverpool Heart and Chest Hospital , Liverpool, L14 3PE,","place":["United Kingdom"]},{"name":"Institute of Life Course and Medical Sciences, University of Liverpool , Liverpool, Liverpool, L7 8TX,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Marc","family":"Gillinov","sequence":"additional","affiliation":[{"name":"Cardiac Surgery, Cleveland Clinic , Cleveland, OH, 44195,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke J","family":"Rogers","sequence":"additional","affiliation":[{"name":"Academic Cardiovascular Unit, South Tees NHS Foundation Trust , Middlesbrough, TS6 0SZ,","place":["United Kingdom"]},{"name":"Department of Surgery, Hull York Medical School , Hull, HU6 7RU,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Maier","sequence":"additional","affiliation":[{"name":"Academic Cardiovascular Unit, South Tees NHS Foundation Trust , Middlesbrough, TS6 0SZ,","place":["United Kingdom"]},{"name":"Academic Cardiovascular Unit, University of Newcastle , Newcastle, NE1 7RU,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimondo","family":"Ascione","sequence":"additional","affiliation":[{"name":"Bristol Heart Institute, University of Bristol Medical School , Bristol, BS2 8HW,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Asopa","sequence":"additional","affiliation":[{"name":"Cardiac Surgery, University Hospital Southampton , Southampton, SO16 6YD,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2429-3579","authenticated-orcid":false,"given":"Enoch","family":"Akowuah","sequence":"additional","affiliation":[{"name":"Academic Cardiovascular Unit, South Tees NHS Foundation Trust , Middlesbrough, TS6 0SZ,","place":["United Kingdom"]},{"name":"Academic Cardiovascular Unit, University of Newcastle , Newcastle, NE1 7RU,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"2026101407414474900_ezag204-B1","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1097\/01.SMJ.0000136235.11281.EB","article-title":"Virchow\u2019s triad?","volume":"97","author":"Dickson","year":"2004","journal-title":"South Med J"},{"key":"2026101407414474900_ezag204-B2","doi-asserted-by":"publisher","first-page":"1047244","DOI":"10.3389\/fcvm.2023.1047244","article-title":"Flow dynamic assessment of native mitral valve, mitral valve repair and mitral valve replacement using vector flow mapping intracardiac flow dynamic in mitral valve regurgitation","volume":"10","author":"Pugliese","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"2026101407414474900_ezag204-B3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12968-022-00882-0","article-title":"Rationale and clinical applications of 4D flow cardiovascular magnetic resonance in assessment of valvular heart disease: a comprehensive review","volume":"24","author":"Gorecka","year":"2022","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026101407414474900_ezag204-B4","doi-asserted-by":"publisher","first-page":"qyaf022","DOI":"10.1093\/ehjimp\/qyaf022","article-title":"Intracardiac flow dynamics in mitral regurgitation: state of the art","volume":"3","author":"Serio","year":"2025","journal-title":"Eur Heart J Imaging Methods Pract"},{"key":"2026101407414474900_ezag204-B5","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1182\/blood.V71.5.1366.1366","article-title":"Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin","volume":"71","author":"Moake","year":"1988","journal-title":"Blood"},{"key":"2026101407414474900_ezag204-B6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1378\/chest.108.1.99","article-title":"Left atrial spontaneous echo contrast in patients with rheumatic mitral valve disease in sinus rhythm: implication of an altered left atrial appendage function in its formation","volume":"108","author":"Li","year":"1995","journal-title":"Chest"},{"key":"2026101407414474900_ezag204-B7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.amjcard.2021.01.006","article-title":"Effect of mitral regurgitation on thrombotic risk in patients with nonrheumatic atrial fibrillation: a new CHA2DS2-VASc score risk modifier?","volume":"145","author":"Van Laer","year":"2021","journal-title":"Am J Cardiol"},{"key":"2026101407414474900_ezag204-B8","doi-asserted-by":"publisher","first-page":"101126","DOI":"10.1016\/j.ijcha.2022.101126","article-title":"Risk of stroke or systemic embolism in patients with degenerative mitral stenosis with or without atrial fibrillation: a cohort study","volume":"43","author":"Steiner","year":"2022","journal-title":"Int J Cardiol Heart Vasc"},{"key":"2026101407414474900_ezag204-B9","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1016\/j.jacc.2014.02.537","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"63","author":"Nishimura","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026101407414474900_ezag204-B10","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1161\/CIR.0000000000000923","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"2026101407414474900_ezag204-B11","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1056\/NEJMoa2209051","article-title":"Rivaroxaban in rheumatic heart disease-associated atrial fibrillation","volume":"387","author":"Connolly","year":"2022","journal-title":"N Engl J Med"},{"key":"2026101407414474900_ezag204-B12","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1161\/STROKEAHA.116.016022","article-title":"Risk of stroke in patients with heart failure","volume":"48","author":"Adelborg","year":"2017","journal-title":"Stroke"},{"key":"2026101407414474900_ezag204-B13","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1161\/STROKEAHA.111.628479","article-title":"Chronic heart failure and ischemic stroke","volume":"42","author":"Haeusler","year":"2011","journal-title":"Stroke"},{"key":"2026101407414474900_ezag204-B14","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1161\/CIRCHEARTFAILURE.114.001725","article-title":"Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: warfarin versus aspirin in reduced cardiac ejection fraction trial substudy","volume":"8","author":"Homma","year":"2015","journal-title":"Circ Heart Fail"},{"key":"2026101407414474900_ezag204-B15","doi-asserted-by":"publisher","first-page":"102431","DOI":"10.1016\/j.rpth.2024.102431","article-title":"Mitral regurgitation is associated with similar loss of von Willebrand factor large multimers but lower frequency of anemia compared with aortic stenosis","volume":"8","author":"Takiguchi","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"2026101407414474900_ezag204-B16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/clc.23538","article-title":"Acquired von Willebrand syndrome and factor VIII in patients with moderate to severe mitral regurgitation undergoing transcatheter mitral valve repair","volume":"44","author":"Meindl","year":"2021","journal-title":"Clin Cardiol"},{"key":"2026101407414474900_ezag204-B17","doi-asserted-by":"publisher","first-page":"638","DOI":"10.3390\/ma3010638","article-title":"Current strategies in cardiovascular biomaterial functionalization","volume":"3","author":"Schopka","year":"2010","journal-title":"Materials"},{"key":"2026101407414474900_ezag204-B18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1136\/hrt.43.3.301","article-title":"Coagulation studies in rheumatic heart disease","volume":"43","author":"Toy","year":"1980","journal-title":"Br Heart J"},{"key":"2026101407414474900_ezag204-B19","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1136\/bmj.1.5027.1089","article-title":"Plasma fibrinogen in rheumatic fever","volume":"1","author":"Reid","year":"1957","journal-title":"Br Med J"},{"key":"2026101407414474900_ezag204-B20","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1080\/09674845.2015.11666804","article-title":"Elevated fibrinogen and lowered homocysteine-vitamin determinants and their association with left atrial thrombus in patients with rheumatic mitral stenosis","volume":"72","author":"Murugesan","year":"2015","journal-title":"Br J Biomed Sci"},{"key":"2026101407414474900_ezag204-B21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.20452\/pamw.16819","article-title":"Impact of transcatheter edge-to-edge valve repair on hemostasis in patients with severe mitral regurgitation: key findings from the mitral fibrin study","volume":"134","author":"Bagoly","year":"2024","journal-title":"Pol Arch Intern Med"},{"key":"2026101407414474900_ezag204-B22","doi-asserted-by":"publisher","first-page":"A104","DOI":"10.1016\/j.jvs.2007.02.048","article-title":"Novel thromboresistant materials","volume":"45","author":"Jordan","year":"2007","journal-title":"J Vasc Surg"},{"key":"2026101407414474900_ezag204-B23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1525-1594.2007.00391.x","article-title":"The effect of surface roughness on activation of the coagulation system and platelet adhesion in rotary blood pumps","volume":"31","author":"Linneweber","year":"2007","journal-title":"Artif Organs"},{"key":"2026101407414474900_ezag204-B24","doi-asserted-by":"publisher","first-page":"e2301039","DOI":"10.1002\/adhm.202301039","article-title":"Unravelling surface modification strategies for preventing medical device-induced thrombosis","volume":"13","author":"Luu","year":"2024","journal-title":"Adv Healthc Mater"},{"key":"2026101407414474900_ezag204-B25","doi-asserted-by":"publisher","first-page":"e002322","DOI":"10.1161\/JAHA.115.002322","article-title":"Dabigatran is less effective than warfarin at attenuating mechanical heart valve-induced thrombin generation","volume":"4","author":"Jaffer","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"2026101407414474900_ezag204-B26","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.jtcvs.2021.07.052","article-title":"Valve thrombosis after transcatheter and surgical aortic valve replacement: incidence and outcomes","volume":"163","author":"Cahill","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026101407414474900_ezag204-B27","doi-asserted-by":"publisher","author":"Kiko\u00efne","year":"2026","DOI":"10.4244\/EIJ-D-20-00991"},{"key":"2026101407414474900_ezag204-B28","doi-asserted-by":"publisher","author":"Jilaihawi","year":"2026","DOI":"10.4244\/EIJV16I17A253"},{"key":"2026101407414474900_ezag204-B29","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1093\/eurheartj\/ehaf194","article-title":"2025 ESC\/EACTS guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"46","author":"Praz","year":"2025","journal-title":"Eur Heart J"},{"key":"2026101407414474900_ezag204-B30","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"2026101407414474900_ezag204-B31","doi-asserted-by":"publisher","first-page":"e1-e156","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"2026101407414474900_ezag204-B32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1161\/01.STR.26.1.7","article-title":"Risk of stroke with mitral valve prolapse in population-based cohort study","volume":"26","author":"Orencia","year":"1995","journal-title":"Stroke"},{"key":"2026101407414474900_ezag204-B33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ijcard.2009.06.051","article-title":"Relation of the severity of mitral regurgitation to thromboembolic risk in patients with atrial fibrillation","volume":"146","author":"Fukuda","year":"2011","journal-title":"Int J Cardiol"},{"key":"2026101407414474900_ezag204-B34","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3390\/jcm8060835","article-title":"Endothelial dysfunction in patients with severe mitral regurgitation","volume":"8","author":"Porro","year":"2019","journal-title":"J Clin Med"},{"key":"2026101407414474900_ezag204-B35","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1161\/01.STR.0000072274.12041.FF","article-title":"Cerebral ischemic events after diagnosis of mitral valve prolapse","volume":"34","author":"Avierinos","year":"2003","journal-title":"Stroke"},{"key":"2026101407414474900_ezag204-B36","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jcmg.2018.01.009","article-title":"Mitral valve regurgitation in the contemporary era: insights into diagnosis, management, and future directions","volume":"11","author":"El Sabbagh","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026101407414474900_ezag204-B37","year":"2026"},{"key":"2026101407414474900_ezag204-B38","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/eurjhf\/hfs171","article-title":"Updated meta-analysis on antithrombotic therapy in patients with heart failure and sinus rhythm","volume":"15","author":"Hopper","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026101407414474900_ezag204-B39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1161\/CIRCHEARTFAILURE.113.000132","article-title":"Aspirin use in heart failure","volume":"7","author":"Bermingham","year":"2014","journal-title":"Circ: Heart Fail"},{"key":"2026101407414474900_ezag204-B40","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1161\/CIR.0b013e31829e8776","article-title":"2013 ACCF\/AHA guideline for the management of heart failure","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"2026101407414474900_ezag204-B41","doi-asserted-by":"publisher","first-page":"e23784","DOI":"10.7759\/cureus.23784","article-title":"Risk of stroke with mitral stenosis: the underlying mechanism, treatment, and prevention","volume":"14","author":"Islam","year":"2022","journal-title":"Cureus"},{"key":"2026101407414474900_ezag204-B42","doi-asserted-by":"publisher","first-page":"885","DOI":"10.7326\/0003-4819-128-11-199806010-00001","article-title":"Predictors of systemic embolism in patients with mitral stenosis: a prospective study","volume":"128","author":"Chiang","year":"1998","journal-title":"Ann Intern Med"},{"key":"2026101407414474900_ezag204-B43","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.jacc.2007.10.058","article-title":"Thromboembolic complications after surgical correction of mitral regurgitation","volume":"51","author":"Russo","year":"2008","journal-title":"JACC"},{"key":"2026101407414474900_ezag204-B44","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","article-title":"Guidelines on the management of valvular heart disease (version 2012)","volume":"33","author":"Vahanian","year":"2012","journal-title":"Eur Heart J"},{"key":"2026101407414474900_ezag204-B45","doi-asserted-by":"publisher","DOI":"10.1101\/2022.10.29.22281662","volume-title":"medRxiv","author":"Kirmani","year":"2022"},{"key":"2026101407414474900_ezag204-B46","doi-asserted-by":"publisher","first-page":"e003158","DOI":"10.1136\/openhrt-2024-003158","article-title":"Efficacy and safety of anti-thrombotic therapy after surgical mitral valve repair: a scoping review","volume":"12","author":"Babadagli","year":"2025","journal-title":"Open Heart"},{"key":"2026101407414474900_ezag204-B47","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jtcvs.2021.01.127","article-title":"Efficacy and safety of edoxaban in patients early after surgical bioprosthetic valve implantation or valve repair: a randomized clinical trial","volume":"165","author":"Shim","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026101407414474900_ezag204-B48","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1186\/s12872-025-04974-4","article-title":"Optimizing antithrombotic therapy following mitral valve repair: a comprehensive network meta-analysis","volume":"25","author":"Gbreel","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"key":"2026101407414474900_ezag204-B49","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/j.athoracsur.2013.03.024","article-title":"Variation in warfarin thromboprophylaxis after mitral valve repair: does equipoise exist and is a randomized trial warranted?","volume":"95","author":"Suri","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"2026101407414474900_ezag204-B50","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.amjcard.2023.10.002","article-title":"Oral anticoagulation versus antiplatelet treatment after mitral valve repair: a systematic review and meta-analysis","volume":"210","author":"Tom\u0161i\u010d","year":"2024","journal-title":"Am J Cardiol"},{"key":"2026101407414474900_ezag204-B51","doi-asserted-by":"publisher","first-page":"e026666","DOI":"10.1161\/JAHA.122.026666","article-title":"Direct oral anticoagulants versus warfarin in patients with atrial fibrillation and valve replacement or repair","volume":"11","author":"Mentias","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2026101407414474900_ezag204-B52","doi-asserted-by":"publisher","year":"2026","DOI":"10.1186\/ISRCTN13146458"},{"key":"2026101407414474900_ezag204-B53","doi-asserted-by":"publisher","first-page":"e576S","DOI":"10.1378\/chest.11-2305","article-title":"Antithrombotic and thrombolytic therapy for valvular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Whitlock","year":"2012","journal-title":"Chest"},{"key":"2026101407414474900_ezag204-B54","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1056\/NEJM198101293040503","article-title":"Five to eight-year follow-up of patients undergoing porcine heart-valve replacement","volume":"304","author":"Cohn","year":"1981","journal-title":"N Engl J Med"},{"key":"2026101407414474900_ezag204-B55","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.amjcard.2013.06.014","article-title":"Diagnosis and treatment of early bioprosthetic malfunction in the mitral valve position due to thrombus formation","volume":"112","author":"Butnaru","year":"2013","journal-title":"Am J Cardiol"},{"key":"2026101407414474900_ezag204-B56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/europace\/euy151","article-title":"Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating \u2018valvular heart disease\u2019 in a nationwide cohort study","volume":"21","author":"Lip","year":"2019","journal-title":"Europace"},{"key":"2026101407414474900_ezag204-B57","doi-asserted-by":"publisher","first-page":"e005835","DOI":"10.1161\/JAHA.117.005835","article-title":"Effects of non\u2013vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and valvular heart disease: a systematic review and meta-analysis","volume":"6","author":"Pan","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2026101407414474900_ezag204-B58","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa2029603","article-title":"Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve","volume":"383","author":"Guimar\u00e3es","year":"2020","journal-title":"N Engl J Med"},{"key":"2026101407414474900_ezag204-B59","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"2026101407414474900_ezag204-B60","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.jtcvs.2025.08.046","article-title":"Oral anticoagulation in patients with atrial fibrillation and heart valve prosthesis: a substudy from the left atrial appendage occlusion study (LAAOS) III trial","volume":"171","author":"Paparella","year":"2026","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026101407414474900_ezag204-B61","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.amjcard.2023.07.141","article-title":"An evidence-based approach to anticoagulation therapy comparing direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation and bioprosthetic valves: a systematic review, meta-analysis, and network meta-analysis","volume":"206","author":"Suppah","year":"2023","journal-title":"Am J Cardiol"},{"key":"2026101407414474900_ezag204-B62","doi-asserted-by":"publisher","first-page":"e0188482","DOI":"10.1371\/journal.pone.0188482","article-title":"The importance of mean time in therapeutic range for complication rates in warfarin therapy of patients with atrial fibrillation: a systematic review and meta-regression analysis","volume":"12","author":"Vestergaard","year":"2017","journal-title":"PLoS One"},{"key":"2026101407414474900_ezag204-B63","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.thromres.2015.10.031","article-title":"Warfarin treatment complications do not correlate to cTTR when above 70","volume":"136","author":"Sand\u00e9n","year":"2015","journal-title":"Thromb Res"},{"key":"2026101407414474900_ezag204-B64","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N Engl J Med"},{"key":"2026101407414474900_ezag204-B65","doi-asserted-by":"publisher","first-page":"EVIDoa2300067","DOI":"10.1056\/EVIDoa2300067","article-title":"Apixaban or warfarin in patients with an On-X mechanical aortic valve","volume":"2","author":"Wang","year":"2023","journal-title":"NEJM Evid"},{"key":"2026101407414474900_ezag204-B66","doi-asserted-by":"publisher","first-page":"CD003464","DOI":"10.1002\/14651858.CD003464.pub2","article-title":"Antiplatelet and anticoagulation for patients with prosthetic heart valves","volume":"2013","author":"Massel","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2026101407414474900_ezag204-B67","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1378\/chest.127.1.53","article-title":"Thromboembolic and bleeding complications following St. Jude medical valve replacement: results of the German experience with low-intensity anticoagulation study","volume":"127","author":"Hering","year":"2005","journal-title":"Chest"},{"key":"2026101407414474900_ezag204-B68","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"2026101407414474900_ezag204-B69","doi-asserted-by":"publisher","first-page":"621258","DOI":"10.3389\/fcvm.2021.621258","article-title":"Transcatheter mitral valve replacement and thrombosis: a review","volume":"8","author":"Ascione","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2026101407414474900_ezag204-B70","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1161\/CIRCULATIONAHA.121.054305","article-title":"Antithrombotic therapy in patients undergoing transcatheter interventions for structural heart disease","volume":"144","author":"Calabr\u00f2","year":"2021","journal-title":"Circulation"},{"key":"2026101407414474900_ezag204-B71","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jacc.2023.10.031","article-title":"Comparison of direct oral anticoagulants vs vitamin K antagonists after transcatheter mitral valve replacement","volume":"83","author":"El B\u00e8ze","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026101407414474900_ezag204-B72","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.121.054305"},{"key":"2026101407414474900_ezag204-B73","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1055\/s-0039-1694751","article-title":"Thrombogenicity and antithrombotic strategies in structural heart interventions and nonaortic cardiac device therapy-current evidence and practice","volume":"119","author":"Geisler","year":"2019","journal-title":"Thromb Haemost"},{"key":"2026101407414474900_ezag204-B74","doi-asserted-by":"publisher","first-page":"e038834","DOI":"10.1161\/JAHA.124.038834","article-title":"Direct oral anticoagulants versus vitamin K antagonists after mitral valve transcatheter edge-to-edge repair in patients with atrial fibrillation: a single-center observational study","volume":"14","author":"Schipper","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"2026101407414474900_ezag204-B75","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/jpm15050197","article-title":"One-stop mitral valve transcatheter edge-to-edge repair and left atrial appendage occlusion in patients with atrial fibrillation and mitral regurgitation: a systematic review and meta-analysis","volume":"15","author":"Pamporis","year":"2025","journal-title":"J Pers Med"},{"key":"2026101407414474900_ezag204-B76","doi-asserted-by":"publisher","first-page":"ivae089","DOI":"10.1093\/icvts\/ivae089","article-title":"Antithrombotic therapy after heart valve surgery: contemporary practice in the UK","volume":"38","author":"Laskar","year":"2024","journal-title":"Interdiscip Cardiovasc Thorac Surg"},{"key":"2026101407414474900_ezag204-B77","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1111\/j.1538-7836.2009.03639.x","article-title":"A breathtaking and bloodcurdling story of coagulation and inflammation in acute lung injury","volume":"7","author":"Schultz","year":"2009","journal-title":"J Thromb Haemost"},{"key":"2026101407414474900_ezag204-B78","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1161\/01.CIR.0000131660.51520.9A","article-title":"Bidirectional relation between inflammation and coagulation","volume":"109","author":"Levi","year":"2004","journal-title":"Circulation"},{"key":"2026101407414474900_ezag204-B79","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1253\/circj.CJ-14-1057","article-title":"Target intensity of anticoagulation with warfarin in Japanese patients with valvular atrial fibrillation\u2013subanalysis of the J-RHYTHM registry","volume":"79","author":"Kodani","year":"2015","journal-title":"Circ J"},{"key":"2026101407414474900_ezag204-B80","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1056\/NEJMoa2510703","article-title":"Bleeding risk with apixaban vs. rivaroxaban in acute venous thromboembolism","volume":"394","author":"Castellucci","year":"2026","journal-title":"N Engl J Med"}],"container-title":["European Journal of Cardio-Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejcts\/advance-article-pdf\/doi\/10.1093\/ejcts\/ezag204\/70381487\/ezag204.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/68\/9\/ezag204\/70381487\/ezag204.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/68\/9\/ezag204\/70381487\/ezag204.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:41:49Z","timestamp":1791978109000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejcts\/article\/doi\/10.1093\/ejcts\/ezag204\/8747156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":80,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,7]]}},"URL":"https:\/\/doi.org\/10.1093\/ejcts\/ezag204","relation":{},"ISSN":["1010-7940","1873-734X"],"issn-type":[{"value":"1010-7940","type":"print"},{"value":"1873-734X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,7,29]]},"article-number":"ezag204"}}